Metagenomi Therapeutics (MGX) Preferred Shares Issued (2023)

Metagenomi Therapeutics (MGX) reported Preferred Shares Issued of $4.3 million for Q1 2023.

Metagenomi Therapeutics (MGX) Preferred Shares Issued (2023) Analysis & Trends

Metagenomi Therapeutics (MGX) has 1 years of Preferred Shares Issued data on file, last reported at $4.3 million in Q1 2023.

Preferred Shares Issued for Q1 2023 came in at $4.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $4.3 million (changed N/A YoY), and the FY2025 annual result was $202000.0, changed N/A from the prior year.
Preferred Shares Issued held at $4.3 million in Q1 2023 per MGX's latest filing.
Over five years, Preferred Shares Issued peaked at $4.3 million in Q1 2023 and troughed at $4.3 million in Q1 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	821,726.73 Bn	821,726.69 Bn	-	-
2	Belite Bio	57,768.00 Bn	57,768.00 Bn	-	-
3	Quantum Biopharma	16,655.88 Bn	16,655.88 Bn	-	-
4	Legend Biotech	3,540.00 Bn	3,539.71 Bn	242.10 Mn	-
5	Evaxion A	1,526.26 Bn	1,526.24 Bn	-	-
6	Akari Therapeutics	1,520.09 Bn	1,520.09 Bn	-	-
7	Psyence Biomedical	223.87 Bn	223.87 Bn	-	-
8	Vertex Pharmaceuticals	114.47 Bn	107.23 Bn	2.59 Bn	-
9	Abivax	91.22 Bn	91.22 Bn	-	-
10	Metagenomi Therapeutics	42.84 Mn	42.84 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2023	4.30 Mn
Mar 31, 2023	4.30 Mn